The Role of Epstein-Barr Virus in Hodgkin Lymphoma
Author Information
Author(s): Giuseppina Massini, Doerte Siemer, Stefan Hohaus
Primary Institution: Istituto di Ematologia, Università Cattolica S. Cuore, Rome, Italy
Hypothesis
What is the role of Epstein-Barr virus (EBV) in the pathogenesis of Hodgkin lymphoma (HL)?
Conclusion
EBV is significantly associated with Hodgkin lymphoma, influencing its pathogenesis and immune response.
Supporting Evidence
- Up to 40% of Hodgkin lymphoma cases are associated with EBV.
- EBV alters the immune response in Hodgkin lymphoma, favoring a Th1 reaction.
- Circulating EBV-DNA may serve as a biomarker for monitoring therapy response.
Takeaway
This study explains how a virus called Epstein-Barr can cause a type of cancer called Hodgkin lymphoma, affecting how the body fights the disease.
Methodology
The review discusses various studies linking EBV to Hodgkin lymphoma, focusing on its biological and epidemiological aspects.
Limitations
The review does not cover all potential infectious agents associated with Hodgkin lymphoma.
Participant Demographics
The review mentions that EBV is more frequent in males, children, and older adults, particularly in developing countries.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website